Atlas Trials

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Clinical trial NCT01811368 · UNKNOWN

Trial details

NCT number
NCT01811368
Sponsor
Joseph Tuscano
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Non Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Start date
2013-03-12
Primary completion
2023-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.